Soleus Capital Management, L.P. Portfolio Holdings

Soleus Capital Management, L.P.

  • $1.21 Billion
  • Q1 2025

Soleus Capital Management, L.P. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.21 Billion distributed in 75 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tg Therapeutics, Inc. with a value of $112M, Novo Cure LTD with a value of $98.4M, Krystal Biotech, Inc. with a value of $79.6M, Biomarin Pharmaceutical Inc with a value of $76.3M, and Organogenesis Holdings Inc. with a value of $53.9M.

Examining the 13F form we can see an decrease of $228M in the current position value, from $1.44B to 1.21B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.21 Billion
Healthcare: $1.09 Billion
ETFs: $114 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$205M
$1.55 Million 0.13% of portfolio
349,982
Q4 2024 Reduced 12.5%
$829M
$1.59 Million 0.13% of portfolio
72,300
Q1 2025 Reduced 60.56%
$337M
$1.55 Million 0.13% of portfolio
686,953
Q1 2025 Reduced 12.71%
$489M
$1.11 Million 0.09% of portfolio
45,000
Q1 2025 New
$42.1M
$210,000 0.02% of portfolio
192,670
Q2 2024 New
$1.68B
$74,000 0.01% of portfolio
10,000
Q1 2025 Reduced 99.66%
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 95.08%
Verastem Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 57.15%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 141.33%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 77.14%
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 75.35%
Theratechnologies Inc
-
$0 0.0% of portfolio
-
Q4 2023 Added 105.95%
Beta Bionics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Calcimedica Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q1 2025 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 11.22%
Inhibikase Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2024 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 7.61%
Septerna Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 11.24%
Sionna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Rigel Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 20.96%

Summary

  • Portfolio
  • No. of Stocks 75
  • Current Value $1.21 Billion
  • Prior Value $1.44 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 17 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email